ClinicalTrials.Veeva

Menu

Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy

O

Osama Mohammad Ali ElDamshety

Status

Completed

Conditions

Cervical Cancer

Treatments

Procedure: laparoscopic nerve-sparing radical hysterectomy-type III/C1
Procedure: laparoscopic radical hysterectomy (type III/C2).

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to assess:

  1. Evaluation of the feasibility of laparoscopic nerve sparing radical hysterectomy type III/C1 as regard surgical technique, blood loss and operative time.
  2. Evaluate patients' outcome as regard bladder function.

in order to preserve the function of the bladder and the rectum, it is necessary to modify the traditional procedures, so as to identify the precise anatomical information directing the technique for optimal preservation of bladder function at the time of radical hysterectomy.

The laparoscopic technique offers several well-known advantages. Under the magnified view of the laparoscope, the anatomy can be clearly visualized to allow for the meticulous and precise dissection of the para-cervical structures and areolar tissue, including the blood vessels and the nerves.

Laparoscopic identification (neurolysis) of the inferior hypogastric nerve and inferior hypogastric plexus is a feasible procedure for trained laparoscopic surgeons who have a good knowledge not only of the retroperitoneal anatomy but also of the pelvic neuro-anatomy as this qualification could prohibit long-term bladder and voiding dysfunction during nerve-sparing radical hysterectomy

Enrollment

46 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age > 18 years.
  2. Karnofsky > 80, or American Society of anaethesiology (ASA) I-II
  3. Stage IA2-IB1-IB2-IIA1-IIA2-IIB cervical cancer according to FIGO (International Federation of Gynecology and Obstetrics) staging.
  4. Stage II, III endometrial cancer

Exclusion criteria

  1. Non Invasive Cancer
  2. Pregnancy
  3. Bladder dysfunction detected prior to surgery.
  4. Previous pelvic lymphadenectomy.
  5. Tumour recurrence
  6. Incomplete surgery, unresectable lesion.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

46 participants in 2 patient groups

Group (A)
Active Comparator group
Description:
laparoscopic nerve sparing radical hysterectomy type III/C1
Treatment:
Procedure: laparoscopic nerve-sparing radical hysterectomy-type III/C1
Group (B)
Active Comparator group
Description:
laparoscopic radical hysterectomy type III/C2
Treatment:
Procedure: laparoscopic radical hysterectomy (type III/C2).

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems